Egea Biosciences Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 40


  • Latest Deal Type
  • M&A

Egea Biosciences General Information


Developer of protein drugs. The company's technology platform creates large libraries of proteins with directed single amino acid changes based on any imagined structure as programmed in a computer in order to revolutionize protein drug development and optimization.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Johnson & Johnson
Corporate Office
  • 6759 Mesa Ridge Road
  • Suite 100
  • San Diego, CA 92121
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Egea Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 18-May-2004 Completed Generating Revenue
5. Grant 16-Jan-2004 00000 Completed Generating Revenue
4. Grant 31-May-2003 00000 Completed Generating Revenue
3. Grant 31-Jan-2002 00000 Completed Generating Revenue
2. Grant 28-Dec-2000 $317K Completed Generating Revenue
1. Early Stage VC 01-Jan-2000 Completed Startup
To view Egea Biosciences’s complete valuation and funding history, request access »

Egea Biosciences Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Egea Biosciences Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hamilton BioVentures Venture Capital Minority 000 0000 000000 0
United States Army Government 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
To view Egea Biosciences’s complete investors history, request access »

Egea Biosciences FAQs

  • When was Egea Biosciences founded?

    Egea Biosciences was founded in 2000.

  • Who is the founder of Egea Biosciences?

    Glen Evans MD is the founder of Egea Biosciences.

  • Where is Egea Biosciences headquartered?

    Egea Biosciences is headquartered in San Diego, CA.

  • What is the size of Egea Biosciences?

    Egea Biosciences has 40 total employees.

  • What industry is Egea Biosciences in?

    Egea Biosciences’s primary industry is Drug Discovery.

  • Is Egea Biosciences a private or public company?

    Egea Biosciences is a Private company.

  • What is Egea Biosciences’s current revenue?

    The current revenue for Egea Biosciences is 000000.

  • Who are Egea Biosciences’s investors?

    Hamilton BioVentures, United States Army, and United States Department of Defense have invested in Egea Biosciences.

  • When was Egea Biosciences acquired?

    Egea Biosciences was acquired on 18-May-2004.

  • Who acquired Egea Biosciences?

    Egea Biosciences was acquired by Johnson & Johnson.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »